These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10717578

  • 41. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
    Murphy RL.
    Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
    [Abstract] [Full Text] [Related]

  • 42. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA, Akinsete L, Abalaka AD, Keshinro LB, Dutse L, Onyenekwe B, Lhekwaba A, Njoku OS, Kehinde MO, Wambebe CO.
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. WHO hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic.
    Fleck F.
    Bull World Health Organ; 2004 Jan; 82(1):77-8. PubMed ID: 15106303
    [No Abstract] [Full Text] [Related]

  • 46. Zidovudine + lamivudine: new preparation. Fewer tablets required.
    Prescrire Int; 1999 Apr; 8(40):39-40. PubMed ID: 10848057
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [HIV post-exposure prophylaxis after sexual risk contact].
    Battegay M, Zimmerli W.
    Schweiz Med Wochenschr; 1999 Feb 27; 129(8):311-3. PubMed ID: 10189667
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Death and HIV infection].
    Van Vooren JP.
    Rev Med Brux; 1998 Feb 27; 19(1):A37-40. PubMed ID: 9553455
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.
    Katzenstein TL, Dickmeiss E, Aladdin H, Hede A, Nielsen C, Nielsen H, Jørgensen LB, Gerstoft J.
    Ann Intern Med; 2000 Jul 04; 133(1):31-4. PubMed ID: 10877737
    [No Abstract] [Full Text] [Related]

  • 57. First clinical data presented on FortovAse.
    AIDS Patient Care STDS; 1997 Dec 04; 11(6):455. PubMed ID: 11361868
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Guidelines for processing cervicovaginal smears from women with acquired immunodeficiency syndrome or the human immunodeficiency virus.
    Hoda SA, Melamed MR.
    Acta Cytol; 1992 Dec 04; 36(1):108-9. PubMed ID: 1546505
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.